TP53 and cancer: The most advanced SSO with demonstrated activity in cancer in vivo currently include STAT3 and other non transcriptional proteins, such as the apoptotic regulator BCL2L1, the signal transducers ERBB4 and the p53 regulator MDM4 [184].